Tradestie Institutional Equity Comparison Engine

SNYR vs ABP โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-09-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SNYR Overall Edge

SNYR Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Synergy CHC Corp. Common Stock (SNYR) driven by superior Valuation, Momentum & Technical while ABP counters with relative strength in Growth & Margin. Fundamentally, SNYR trades at 0.6x Forward P/E with -10.3% operating margin (-32.8% YoY revenue) versus ABP at N/M Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, SNYR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ABP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner SNYR
SNYR 0.6x vs ABP N/M Fwd P/E
Growth & Margin Winner ABP
Op Margin -10.3% vs 0.0% ยท YoY -32.8% vs -100.0%
Momentum & Technical Winner SNYR
1Y -96.2% vs -98.2% ยท 52W Pos 1% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
SNYR NASDAQ
Synergy CHC Corp. Common Stock
Medicinal Chemicals & Botanical Products
$0.09
-67.02% 1D
Market Cap $4.1M
1M Return -16.28%
1Y Return -96.15%
Forward P/E 0.6x
Unified AI Score
48.9 / 100 HOLD
Tech 55.0 Fund 39.0 Flow 50.0 Mom 60.0
ABP NASDAQ
Abpro Holdings, Inc Common Stock
Biological Products, (No Disgnostic Substances)
$0.52
-34.76% 1D
Market Cap $2.2M
1M Return -84.04%
1Y Return -98.23%
Forward P/E N/M
Unified AI Score
44.4 / 100 HOLD
Tech 40.0 Fund 49.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SNYR -96.15% ABP -98.23% Spread: +52.56 pp (SNYR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SNYR TTM Op. Margin: -10.3% ABP TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SNYR vs ABP. Trailing 12-month operating profitability (SNYR -10.3% vs ABP 0.0%) and valuation multiples (SNYR 0.6x vs ABP N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SNYR (5) vs ABP (4)
Institutional Metric SNYR ABP Criterion Row Winner
Market Capitalization Scale $4.1M $2.2M Larger Scale Tie
Trailing P/E Ratio Valuation 0.6x N/M Lower Multiple SNYR
Forward P/E Ratio Valuation 0.6x N/M Lower Multiple SNYR
Revenue Growth (YoY) Growth -32.8% -100.0% Higher Growth SNYR
Operating Margin (TTM) Profitability -10.3% 0.0% Higher Margin ABP
Net Profit Margin Profitability -57.0% 0.0% Higher Margin ABP
Return on Equity (ROE) Capital Efficiency -361.1% 0.0% Higher ROE ABP
52-Week Range Position Momentum 1% ($0โ€“$3) 0% ($1โ€“$32) Stronger Trend SNYR
Beta / 30D Volatility Risk Regime -0.86ฮฒ ยท 868% Vol 2.33ฮฒ ยท 258% Vol Lower Realized Risk ABP
Unified Institutional Score Composite Signal 48.9 / 100 (HOLD) 44.4 / 100 (HOLD) Higher Composite SNYR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SNYR vs ABP Buy Guide
SNYR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SNYR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ABP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ABP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SNYR nor ABP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.